Elevated snoRNAs and fibrillarin (FBL, an enzymatic snoRNP) expression has been linked to impaired p53 activation and increased tumorigenicity (182), while snoRNA U50, usually downregulated in prostate and breast cancer, has a significant correlation with tumor grade (183). Here, FBL is linked to breast carcinoma.